Delayed presentation of breast cancer patients by Otieno, ES et al.
April 2010 EAST AFRICAN MEDICAL JOURNAL   147
INTRODUCTION
Breast cancer remains a leading cause of death of 
women all over the world. Presentation of patients 
with this cancer in late stage (Manchester III and 
IV) is rare in the Western World (1). On the contrary, 
late stage presentation is common in developing 
countries especially so in the African sub-continent. 
In this region the prevalence of advanced breast 
cancer at presentation ranges between 57 and 95% 
(1-5). Patient delay defines the time lapse between 
noticing a breast symptom and presenting to the 
healthcare provider or facility. Randomised trials 
have established that patient delay of three or more 
months at presentation is associated with significantly 
higher levels of recurrence and lower survival rates 
(6,7). Patient delay accounts for a large proportion of 
those who present with late stage disease especially in 
developing countries. Understanding the factors that 
influence patient delay is critical in order to develop 
effective and targeted interventional programmes 
to shorten this delay and hence provide women 
suffering from breast cancer with a better opportunity 
for survival. 
MATERIALS AND METHODS
Study design and setting: Prospective cross sectional 
study over a two and a half year period from 1st 
October 2003 to  31st March 2006 carried out at Kenyatta 
National Hospital (KNH) in the three surgical firms 
and the breast clinic. The KNH breast clinic was set up 
in the year 2000 as a specialist clinic for the purpose 
of managing all diseases of the breast. It is held once 
a week and run by consultant surgeons and surgical 
residents in training. 
Study population: All patients seen at the KNH breast 
clinic or admitted to the three surgical wards with 
cytologically or histologically diagnosed advanced 
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ABSTRACT
Objective: To determine the extent and nature of delayed presentation of patients 
treated for breast cancer at Kenyatta National Hospital (KNH). 
Design: Prospective cross sectional study. 
Setting: Kenyatta National Hospital (KNH) which is a tertiary, teaching and referral 
hospital in Nairobi, Kenya.
Results: A total of 166 patients were recruited into the study. The mean age was 47 
years with a range between 17 and 88 years. Females constituted 98.8%, had an average 
of 4.5 children per subject with a median of 4 and a range of 0-11. A lump as the first 
noticed symptom present in 87.3% and 52.1% were pre-menopausal. Only 11 (6.62%) 
patients presented within 30 days of discovering their breast symptom, 34 (20.4%) 
presented between thirty and ninety days and the remaining 115 (73.1%) presented 
three months after noticing their symptom. Three reasons accounted for 67.5% of the 
delay. Thirty three (19.9%) kept away fearing that they would be told they had cancer 
while 39 (23.5%) presented late because their breast symptom was painless. Another 
40 (24.1%) said they had earlier visited medical personnel who had reassured them 
that their symptoms were benign. 
Conclusion: Majority of patients treated for advanced breast disease presented to 
the healthcare providers at KNH more than three months after noticing their breast 
symptom and a sizeable number of patients were being reassured falsely that they 
have benign disease without the benefit of biopsy. 
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breast cancer (Manchester classification 1940-Stage 
III and IV) were included in this study. Patients who 
presented with previously treated or recurrent breast 
cancer were excluded from the study. 
Data collection: All patients diagnosed with breast 
cancer who certified the inclusion criteria were 
interviewed by the researchers and socio-clinical 
and demographic data entered into a structured 
questionnaire after written consent was obtained 
from the patient or guardian. 
Ethical issues: Written permission to do the study was 
granted by the Kenyatta National Hospital Research 
and Ethics Committee 
RESULTS
A total of 166 patients were recruited into the study. 
The mean age was 47 years with a range between 
17 and 88 years. Females constituted 98.8%. The 
study population had an average of four point five 
children per subject with a median of four and a 
range of 0-11. A lump as the first noticed symptom 
was seen in 87.3% and 52.1% were pre-menopausal. 
Table 1 summarizes the duration of symptoms in 
three groupings. Three reasons accounted for 67.5% 
of the delay. Thirty three (19.9%) kept away fearing 
that they would be told they had cancer while 39 
(23.5%) presented late because their breast symptom 
was painless. Another 40 (24.1%) said they had earlier 
visited a medical personnel who had reassured them 
that their symptoms were benign. Table 2 gives more 
details of reasons given for the delay. 
DISCUSSION
For purposes of management, breast cancer is 
clinically divided into early and late disease. The 
former constitutes patients presenting with stage I and 
II, while the latter consists of stage III and IV according 
to Manchester classification 1940. Our present day 
knowledge of breast cancer is such that there is no 
effective primary prevention, making it imperative 
to detect the disease early in order to increase the 
likelihood of cure (8). There is indeed increasing 
evidence that patient delay at presentation adversely 
affects survival (6, 7). Richards et al. (9) found that a 
delay of 12 weeks or more resulted in significantly 
higher levels of recurrence and worse survival rates. 
In the West only one third (30%) of women presenting 
with symptomatic breast cancer have a patient delay of 
three or more months (10,11). Even then, presentation 
of breast cancer with advanced disease is rare in the 
developed world owing to awareness campaigns, 
limited practice of breast self examination (BSE) and 
widespread use of mammography screening (11). On 
the contrary, in developing countries and especially 
in Africa, presentation of breast cancer with stage III 
and stage IV is very common (1-5). In Nigeria over the 
last 40 years there has been progressive improvement 
in the stage at presentation of this disease. In the 
1960’s Pearson found a late stage disease prevalence 
of 95%. This dropped to 84% in the 1970’s, 77% in the 
late 1980’s and 57% in the 1990’s (5). Comparatively 
at Muhimbili Medical Centre in Tanzania, Hiza and 
Aziz (3) found that up to 85% of patients with breast 
cancer presented with late stage disease in a study 
done between 1978 to 1982. In the same institution, 
Table 1
Duration of symptoms
Duration of symptoms  Number   Cumulative percentage 
 (n=166) (%)   
< 30 days  11  6.62  6.62 
31- 90 days  34  20.40  27.02 
> 90 days  115  73.08  100.00 
Table 2
Reasons for delayed presentation of patients with stage III and IV disease
Reason for delay Number   Cumulative 
 (n=166) (%) percentage 
Reassured that their condition was benign by 
the first medical personnel they visited 40  24.1  24.1 
Painless symptomatology    39  23.5  47.6 
Worried they would be diagnosed with cancer  33  19.9  67.5 
Attending to traditional healers  
and taking herbal preparations 16  9.6  77.1   
Not aware of the disease    13  7.8  84.9 
others 25  15.1  100 
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Mbonde et al. (2) in a study in the mid 90s found 
that the prevalence rate for late disease was 93%. At 
Mulago Hospital, Uganda, 88% of all patients with 
breast cancer presented to hospital with advanced 
disease in 1988.  In Kenya, while studying post-
surgical management of patients with breast cancer 
at Kenyatta National Hospital, Othieno-Abinya et 
al. (1) found a late prevalence disease of 69.5% in 
patients seen between 1989 to 2000. This trend is 
repeated in most other developing countries (12,13). 
This study does reveal that more than 69.3% of those 
who presented with late disease had patient delay of 
more than three months and that slightly over half 
were pre-menopausal with a mean age of 47 years. 
Efforts all  over the world to catch breast cancer 
early have revolved around creating awareness in 
women, the use of BSE and mammographic screening. 
Randomised trials of mammographic screening 
have provided strong evidence that early diagnosis 
and treatment of breast cancer can reduce specific 
mortality. 
 The worldwide use and efficacy of mammography 
for screening purposes is still controversial. This 
screening modality is not practical in most developing 
countries on account of availability and cost. However 
even where it is available and in use its sensitivity in 
identifying breast cancer is about 80% (14). It is even 
less efficacious in younger women below 40 years of 
age owing the density of the breasts. Indeed, some 
studies have categorically stated that false negative 
mammography findings have led to complacency 
among physicians resulting in late presentation 
of breast cancer (15,16). Langlands and Tivers in 
1982 reported five cases of negative mammograms 
in patients with palpable breast tumors who later 
presented with locally advanced breast cancer (15) 
and Walker noted that failure of mammography to 
define cancer in 95 of 218 patients with breast cancer 
led to serious delay after biopsy was postponed (16). 
However, despite a mammographic accuracy of 83% 
and a false negative rate of 11%, Cregan et al. (14) in 
his series found that this did not contribute to delay 
at presentation or undue postponement of biopsy. 
Mammography alone, however, should not be used 
to exclude presence of breast cancer especially in 
women under 35 years of age with symptomatic 
breast disease without recourse to biopsy. This study 
reports that slightly over 52% of the patients seen 
were pre-menopausal implying a younger population 
among whom mammography screening may have 
low sensitivity. It is also relatively out of reach or 
most patients on account of availability and cost. 
 Breast  Self  Examination (BSE) is an inexpensive, 
easy to perform and quite effective means of detecting 
breast lumps early. In the absence of widespread 
mammographic screening especially in developing 
countries, BSE remains the most pratical way to 
go. Despite high level of awareness this relatively 
cheap but effective tool is not being practised as 
often as it should as the level of skill and motivation 
required for effective BSE is high. Philip et al. (17) 
reported a prospective study of 304 patients with 
newly diagnosed breast cancer and established a 
BSE compliance rate of 54%. The compliant group 
was noted to present with clinically early tumours. A 
general survey in 63 hospitals in Italy found that BSE 
was practiced by 34% (n=1110) and that only 9% of 
these, did it regularly on a monthly basis (18). In this 
study any type of BSE (regular or irregular) resulted 
in smaller primaries at presentation. However, only in 
the regular group was there limited benefit in terms 
of nodal involvement and pathologic staging. It was 
also noted that the benefit that may accrue from timely 
presentation following BSE may be cancelled by 
delays inherent in out healthcare systems (18,19). 
 Indeed, one of the most talked about causes 
of delay at diagnosis continues to be physician 
reassurance to the patient that a breast lump is benign 
without the benefit of biopsy. This factor was quite 
prominent in this study where up to 24.1% gave this as 
the sole reason why they had presented with advanced 
breast disease. This emphasizes the importance that 
physicians must place on biopsy as a gold standard 
for the diagnosis of any lesion in the breast no mater 
how benign it may appear.
 Age and level of education are also independent 
factors likely to predict late stage disease at 
presentation. Ikpat et al (20) in Nigeria noted that 
19.4% of patients aged 40 years and below presented 
with late stage disease compared to 73.3% of patients 
aged over 40 years. Personal, economic, physical and 
socio-cultural factors have also been documented to 
be causes of delay at presentation (21). 
 Breast size and presentation of breast disease 
initially without a lump have been known to cause 
delay (6,21). In Australia it was established that 
whether breast size was assessed in terms of weight 
or thickness (mastectomy specimen), large breasts 
presented consistently with larger tumours and 
more involvement of regional lymph nodes (21). 
Fear of mastectomy and its associated stigma led to 
late presentation in 2154 (44.7%) of all patients with 
breast cancer in Nigeria (22). 
 Preference from the onset for spiritual healing and 
traditional doctors accounted respectively for 13.5% 
and 23.1% of patient delay that resulted in presentation 
with advanced breast disease (19, 22-24). 
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